Skip to main content
Top
Published in: Journal of Orthopaedic Surgery and Research 1/2020

01-12-2020 | Osteonecrosis | Research article

Results of advanced core decompression in patients with osteonecrosis of the femoral head depending on age and sex—a prospective cohort study

Authors: Sebastian Serong, Marcel Haversath, Tjark Tassemeier, Florian Dittrich, Stefan Landgraeber

Published in: Journal of Orthopaedic Surgery and Research | Issue 1/2020

Login to get access

Abstract

Background

Core decompression is a common surgical technique to treat osteonecrosis of the femoral head. The aim of this study is to evaluate the effect of the parameters “age” and “sex” on the outcome of this type of treatment.

Methods

A prospective cohort study was performed. Eighty-six osteonecrotic hips with a mean follow-up of 32.5 months (± 24.8) after advanced core decompression were analysed regarding age- and sex-dependent treatment failure. Additionally, the modified Harris Hip Score and Numeric Rating Scale were compared regarding the parameters age and sex.

Results

The mean hip survival of the male participants was 51.3 months (39.4% treatment failure), whereas females presented a longer, thus not significant, mean survival of 61.4 months (30% therapy failure; p = 0.48). The further evaluation revealed significantly better survival in the patients aged < 40 years (mean survival 66.09 months, 16% treatment failure) in comparison to those aged ≥ 40 years (mean survival 50.14 months, 46% therapy failure; p = 0.03). The modified Harris Hip Score and Numeric Rating Scale results of patients whose treatment did not fail during the study period were similar, irrespective of the patient’s sex or age.

Conclusions

The study shows that the number of therapy failures is significantly higher in older patients, with 40 years of age marking the borderline. Patients’ sex does not seem to affect the outcome of treatment, and postoperative clinical scores appear to be identical with individuals not affected by therapy failure. Since age and sex are unalterable parameters, the study helps to provide valuable predictions regarding the chances of long-term hip survival after treatment of osteonecrosis.
Literature
1.
go back to reference Mont MA, Hungerford DS. Non-traumatic avascular necrosis of the femoral head. J Bone Joint Surg Am. 1995;77:459–74.CrossRef Mont MA, Hungerford DS. Non-traumatic avascular necrosis of the femoral head. J Bone Joint Surg Am. 1995;77:459–74.CrossRef
7.
go back to reference Camporesi E, Vezzani G, Zanon V, Manelli D, Enten G, Quartesan S, Bosco G. Review on hyperbaric oxygen treatment in femoral head necrosis. Undersea Hyperb Med. 2017;44:497–508.CrossRef Camporesi E, Vezzani G, Zanon V, Manelli D, Enten G, Quartesan S, Bosco G. Review on hyperbaric oxygen treatment in femoral head necrosis. Undersea Hyperb Med. 2017;44:497–508.CrossRef
16.
go back to reference Lieberman JR, Conduah A, Urist MR. Treatment of osteonecrosis of the femoral head with core decompression and human bone morphogenetic protein. Clin Orthop Relat Res. 2004:139–45. Lieberman JR, Conduah A, Urist MR. Treatment of osteonecrosis of the femoral head with core decompression and human bone morphogenetic protein. Clin Orthop Relat Res. 2004:139–45.
18.
go back to reference Liu D, Chen Q, Chen Y, Liu Y. Long-term follow-up of early-middle stage avascular necrosis of femoral head with core decompression and bone grafting. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 2012;26:1165–8.PubMed Liu D, Chen Q, Chen Y, Liu Y. Long-term follow-up of early-middle stage avascular necrosis of femoral head with core decompression and bone grafting. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 2012;26:1165–8.PubMed
20.
go back to reference Steinberg ME, Hayken GD, Steinberg DR. A quantitative system for staging avascular necrosis. J Bone Joint Surg Br. 1995;77:34–41.CrossRef Steinberg ME, Hayken GD, Steinberg DR. A quantitative system for staging avascular necrosis. J Bone Joint Surg Br. 1995;77:34–41.CrossRef
24.
go back to reference Gardeniers JWM, Gosling-Gardeniers AC, Rijnen WHC. The ARCO staging system: generation and evolution since 1991. In: Osteonecrosis: Springer; 2014. p. 215–8. Gardeniers JWM, Gosling-Gardeniers AC, Rijnen WHC. The ARCO staging system: generation and evolution since 1991. In: Osteonecrosis: Springer; 2014. p. 215–8.
29.
go back to reference Nötzli HP, Wyss TF, Stoecklin CH, Schmid MR, Treiber K, Hodler J. The contour of the femoral head-neck junction as a predictor for the risk of anterior impingement. J Bone Joint Surg Br. 2002;84:556–60.CrossRef Nötzli HP, Wyss TF, Stoecklin CH, Schmid MR, Treiber K, Hodler J. The contour of the femoral head-neck junction as a predictor for the risk of anterior impingement. J Bone Joint Surg Br. 2002;84:556–60.CrossRef
33.
go back to reference Durnez A, Paternotte S, Fechtenbaum J, Landewé RBM, Dougados M, Roux C, Briot K. Increase in bone density in patients with spondyloarthritis during anti-tumor necrosis factor therapy: 6-year followup study. J Rheumatol. 2013;40:1712–8.CrossRef Durnez A, Paternotte S, Fechtenbaum J, Landewé RBM, Dougados M, Roux C, Briot K. Increase in bone density in patients with spondyloarthritis during anti-tumor necrosis factor therapy: 6-year followup study. J Rheumatol. 2013;40:1712–8.CrossRef
34.
go back to reference Lacey DL, Timms E, Tan HL, Kelley MJ, Dunstan CR, Burgess T, et al. Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell. 1998;93:165–76.CrossRef Lacey DL, Timms E, Tan HL, Kelley MJ, Dunstan CR, Burgess T, et al. Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell. 1998;93:165–76.CrossRef
36.
go back to reference Nandra R, Grover L, Porter K. Fracture non-union epidemiology and treatment. Trauma. 2016;18:3–11.CrossRef Nandra R, Grover L, Porter K. Fracture non-union epidemiology and treatment. Trauma. 2016;18:3–11.CrossRef
37.
go back to reference Robinson CM, Royds M, Abraham A, McQueen MM, Court-Brown CM, Christie J. Refractures in patients at least forty-five years old. a prospective analysis of twenty-two thousand and sixty patients. J Bone Joint Surg Am. 2002;84-A:1528–33.CrossRef Robinson CM, Royds M, Abraham A, McQueen MM, Court-Brown CM, Christie J. Refractures in patients at least forty-five years old. a prospective analysis of twenty-two thousand and sixty patients. J Bone Joint Surg Am. 2002;84-A:1528–33.CrossRef
41.
go back to reference Matthews C, Gorenne I, Scott S, Figg N, Kirkpatrick P, Ritchie A, et al. Vascular smooth muscle cells undergo telomere-based senescence in human atherosclerosis: effects of telomerase and oxidative stress. Circ Res. 2006;99:156–64.CrossRef Matthews C, Gorenne I, Scott S, Figg N, Kirkpatrick P, Ritchie A, et al. Vascular smooth muscle cells undergo telomere-based senescence in human atherosclerosis: effects of telomerase and oxidative stress. Circ Res. 2006;99:156–64.CrossRef
Metadata
Title
Results of advanced core decompression in patients with osteonecrosis of the femoral head depending on age and sex—a prospective cohort study
Authors
Sebastian Serong
Marcel Haversath
Tjark Tassemeier
Florian Dittrich
Stefan Landgraeber
Publication date
01-12-2020
Publisher
BioMed Central
Published in
Journal of Orthopaedic Surgery and Research / Issue 1/2020
Electronic ISSN: 1749-799X
DOI
https://doi.org/10.1186/s13018-020-01643-4

Other articles of this Issue 1/2020

Journal of Orthopaedic Surgery and Research 1/2020 Go to the issue